These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29645021)

  • 1. Correction: MicroRNA-29a increased the intestinal membrane permeability of colonic epithelial cells in irritable bowel syndrome rats.
    Chao G; Wang Y; Zhang S; Yang W; Ni Z; Zheng X
    Oncotarget; 2018 Mar; 9(21):15816. PubMed ID: 29645021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-29a increased the intestinal membrane permeability of colonic epithelial cells in irritable bowel syndrome rats.
    Chao G; Wang Y; Zhang S; Yang W; Ni Z; Zheng X
    Oncotarget; 2017 Oct; 8(49):85828-85837. PubMed ID: 29156760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of adherens junctions between the epithelial cells of intestinal mucosal barrier in irritable bowel syndrome].
    Chen CY; Zhang M; Wang SS; Lü B; Wang X
    Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(14):1065-1070. PubMed ID: 28395430
    [No Abstract]   [Full Text] [Related]  

  • 4. MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1.
    Hou Q; Huang Y; Zhu S; Li P; Chen X; Hou Z; Liu F
    Cell Physiol Biochem; 2017; 44(6):2256-2268. PubMed ID: 29258088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario.
    Marshall JK; Thabane M; Garg AX; Clark W; Meddings J; Collins SM;
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1317-22. PubMed ID: 15606393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
    Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M
    Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased small intestinal permeability and RNA expression profiles of mucosa from terminal ileum in patients with diarrhoea-predominant irritable bowel syndrome.
    Li L; Xiong L; Yao J; Zhuang X; Zhang S; Yu Q; Xiao Y; Cui Y; Chen M
    Dig Liver Dis; 2016 Aug; 48(8):880-7. PubMed ID: 27246797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of microRNA related to irritable bowel syndrome in a rabbit model.
    Yang QQ; Xu XP; Zhao HS; Cai YQ; Pan YM; Xu JQ; Ma QX; Chen ML
    J Dig Dis; 2017 Jun; 18(6):330-342. PubMed ID: 28509372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Colonic Mucosal MicroRNA Expression via Multiple Targets in Visceral Hypersensitivity Rats by Tongxieyaofang.
    Chao G; Wang Y; Ye F; Zhang S
    Yonsei Med J; 2018 Oct; 59(8):945-950. PubMed ID: 30187701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.
    Pimentel M; Chow EJ; Lin HC
    Am J Gastroenterol; 2000 Dec; 95(12):3503-6. PubMed ID: 11151884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-29a mediates the impairment of intestinal epithelial integrity induced by intrauterine growth restriction in pig.
    Zhu Y; Wang W; Yuan T; Fu L; Zhou L; Lin G; Zhao S; Zhou H; Wu G; Wang J
    Am J Physiol Gastrointest Liver Physiol; 2017 May; 312(5):G434-G442. PubMed ID: 28280141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
    Zeng J; Li YQ; Zuo XL; Zhen YB; Yang J; Liu CH
    Aliment Pharmacol Ther; 2008 Oct; 28(8):994-1002. PubMed ID: 18671775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonic Hypermotility in a Rat Model of Irritable Bowel Syndrome Is Associated with Upregulation of TMEM16A in Myenteric Plexus.
    Lin MJ; Yu BP
    Dig Dis Sci; 2018 Dec; 63(12):3329-3338. PubMed ID: 30155840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Visceral Organ Crosstalk: Importance of Alterations in Permeability in Rodent Models.
    Greenwood-Van Meerveld B; Mohammadi E; Tyler K; Van Gordon S; Parker A; Towner R; Hurst R
    J Urol; 2015 Sep; 194(3):804-11. PubMed ID: 25776913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of trimebutine maleate on modulating intestinal hypercontractility in a mouse model of postinfectious irritable bowel syndrome.
    Long Y; Liu Y; Tong J; Qian W; Hou X
    Eur J Pharmacol; 2010 Jun; 636(1-3):159-65. PubMed ID: 20371236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamine Restores Tight Junction Protein Claudin-1 Expression in Colonic Mucosa of Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Bertrand J; Ghouzali I; Guérin C; Bôle-Feysot C; Gouteux M; Déchelotte P; Ducrotté P; Coëffier M
    JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1170-1176. PubMed ID: 25972430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis.
    Gecse K; Róka R; Séra T; Rosztóczy A; Annaházi A; Izbéki F; Nagy F; Molnár T; Szepes Z; Pávics L; Bueno L; Wittmann T
    Digestion; 2012; 85(1):40-6. PubMed ID: 22179430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells.
    Vivinus-Nébot M; Dainese R; Anty R; Saint-Paul MC; Nano JL; Gonthier N; Marjoux S; Frin-Mathy G; Bernard G; Hébuterne X; Tran A; Theodorou V; Piche T
    Am J Gastroenterol; 2012 Jan; 107(1):75-81. PubMed ID: 21931380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: MicroRNA-29a promotes the proliferation of human nasal epithelial cells and inhibits their apoptosis and promotes the development of allergic rhinitis by down-regulating FOS expression.
    PLOS ONE Staff
    PLoS One; 2024; 19(4):e0302708. PubMed ID: 38640092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.